Cargando…
Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
Allogeneic cell therapy products, such as therapeutic cells derived from pluripotent stem cells (PSCs), have amazing potential to treat a wide variety of diseases and vast numbers of patients globally. However, there are various challenges related to the manufacturing of PSCs in large enough quantit...
Autores principales: | Lee, Brian, Borys, Breanna S., Kallos, Michael S., Rodrigues, Carlos A. V., Silva, Teresa P., Cabral, Joaquim M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355837/ https://www.ncbi.nlm.nih.gov/pubmed/32231012 http://dx.doi.org/10.3390/bioengineering7020031 |
Ejemplares similares
-
Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2022) -
Commercial Scale Manufacturing of Allogeneic Cell Therapy
por: Pigeau, Gary M., et al.
Publicado: (2018) -
Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic
por: Colter, James, et al.
Publicado: (2021) -
Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells
por: Rohani, Leili, et al.
Publicado: (2020) -
Stem Cell Bioprocessing and Manufacturing
por: Cabral, Joaquim M.S., et al.
Publicado: (2020)